Cargando…

Third generation cognitive-behavioral therapies for major depressive disorder- a literature review

INTRODUCTION: Cognitive behavioral therapies (CBT) represent a heterogeneous group of psychotherapies in continuous development that share a directive, structured, collaborative approach. Due to a high degree of treatment-resistant cases of major depressive disorder (MDD), new augmentation therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vasile, D., Vasiliu, O., Vasiliu, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471229/ http://dx.doi.org/10.1192/j.eurpsy.2021.873

Ejemplares similares

Mindfulness-based cognitive therapy for major depressive disorder- a literature review
por: Vasile, D., et al.
Publicado: (2021)

Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
por: Vasile, D., et al.
Publicado: (2021)

Management of diabetes mellitus in patients with severe mental disorders using new generation hypoglycemic drugs- A review of the literature
por: Vasiliu, O.
Publicado: (2023)

Therapeutic management of major depression and psoriazis dual diagnosis
por: Vasiliu, O.
Publicado: (2021)

Evidence-based therapeutic management of binge-eating disorder
por: Vasile, D., et al.
Publicado: (2021)

Current pharmacological treatment of fibromyalgia- a literature review
por: Vasiliu, O.
Publicado: (2021)

Burn-out syndrome in healthcare practitioners- a narrative literature review
por: Vasiliu, O.
Publicado: (2021)

Evaluation of executive dysfunction in clinical practice- pragmatic challenges and solutions
por: Vasile, D., et al.
Publicado: (2021)

Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review
por: Vasiliu, Octavian
Publicado: (2023)

Pharmacological Treatment Strategies for Postpartum Depression
por: Vasiliu, O.
Publicado: (2022)

Negative and Cognitive Symptoms of Schizophrenia: Are there Adequate Pharmacological Treatments?
por: Vasiliu, O.
Publicado: (2022)

Evaluation of the executive dysfunction in patients with bipolar disorder
por: Vasiliu, O.
Publicado: (2023)

The analysis of organic diseases in elderly patients diagnosed with bipolar disorders- A retrospective study
por: Vasiliu, O.
Publicado: (2023)

Evidence-based Pharmacological Treatment in the Maintenance Phase of the Type I Bipolar Disorder: Anticonvulsants or Antipsychotics?
por: Vasiliu, O.
Publicado: (2022)

Third generation cognitive-behavioral therapies and genital pain
por: Barbosa, D., et al.
Publicado: (2021)

Professional stress-related disorders in first-line responders- how far are we from real prevention strategies?
por: Vasiliu, O.
Publicado: (2021)

The clinical efficacy of orexin antagonists for primary insomnia- A review of the evidence
por: Vasiliu, O.
Publicado: (2023)

Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
por: Vasiliu, Octavian
Publicado: (2022)

The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
por: Vasiliu, Octavian
Publicado: (2023)

Therapeutic approaches in chronic fatigue syndrome
por: Vasiliu, O.
Publicado: (2021)

Pharmacological Management of insomnia Associated with Parkinson’s Disease
por: Vasiliu, O.
Publicado: (2022)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
por: Vasiliu, O.
Publicado: (2022)

M193. CHANGES IN THEORY OF MIND DETECTED IN SCHIZOPHRENIA SPECTRUM DISORDERS- A LITERATURE REVIEW
por: Vasiliu, Octavian
Publicado: (2020)

Therapeutic management of buying/shopping disorder: A systematic literature review and evidence-based recommendations
por: Vasiliu, Octavian
Publicado: (2022)

The current state of research for psychobiotics use in the management of psychiatric disorders–A systematic literature review
por: Vasiliu, Octavian
Publicado: (2023)

Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second‑generation antipsychotics (Review)
por: Vasiliu, Octavian
Publicado: (2023)

Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)
por: Vasiliu, Octavian
Publicado: (2023)

Current Trends and Perspectives in the Immune Therapy for Substance Use Disorders
por: Vasiliu, Octavian
Publicado: (2022)

S196. TRANSCRANIAL MAGNETIC STIMULATION IN SCHIZOPHRENIA WITH PROMINENT NEGATIVE SYMPTOMS- A REVIEW OF THE LITERATURE
por: Vasiliu, Octavian
Publicado: (2020)

Current Status of Evidence for a New Diagnosis: Food Addiction-A Literature Review
por: Vasiliu, Octavian
Publicado: (2022)

At the Crossroads between Eating Disorders and Body Dysmorphic Disorders—The Case of Bigorexia Nervosa
por: Vasiliu, Octavian
Publicado: (2023)

Cognitive behavioral therapy in obsessive-compulsive disorder: A review
por: Duarte, D.
Publicado: (2021)

Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents
por: Vasiliu, Octavian
Publicado: (2022)

Investigational Drugs for the Treatment of Depression (Part 1): Monoaminergic, Orexinergic, GABA-Ergic, and Anti-Inflammatory Agents
por: Vasiliu, Octavian
Publicado: (2022)

T196. THERAPEUTIC MANAGEMENT IN MULTIPLE SCLEROSIS AND SCHIZOPHRENIA SPECTRUM DISORDERS DUAL DIAGNOSIS
por: Vasiliu, Octavian
Publicado: (2020)

An integrative model as a step toward increasing the awareness of eating disorders in the general population
por: Vasiliu, Octavian
Publicado: (2023)

Effectiveness of Meta-Cognitive and Cognitive-Behavioral Therapy in Patients with Major Depressive Disorder
por: Ashouri, Ahmad, et al.
Publicado: (2013)

Linked patterns of symptoms and cognition with brain controllability in major depressive disorder
por: Li, Q., et al.
Publicado: (2023)

Effects of cognitive-behavioral therapy on neurotrophic factors in patients with major depressive disorder
por: da Silva, Sally K., et al.
Publicado: (2018)

Brain aging in major depressive disorder
por: Han, L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdo335cj4rdmo96o9cvn0n3ngd